Protein Official symbol | CYP26B1 |
Aliases | CYP26B1 CYP26A2 P450RAI2 |
Chromosomal Location | 2 |
Length | 512 |
Uniprot ID | Q9NR63 |
EC number | 1.14.13.- |
Protein family Information(Pfam) | PF00067; |
PDB id | None |
InterPro ID | IPR001128;IPR017972;IPR002403;IPR036396; |
dbSNP | rs281875232 rs142999899 rs765423228 rs76025186 rs143738797 rs2241057 rs281875231 rs2286965 rs7568553 rs61751056 rs148075682 |
Protein 1 | Protein 2 | Combine Score |
---|---|---|
ALDH1A2 | CYP26B1 | 0.977 |
ALDH1A1 | CYP26B1 | 0.957 |
CYP3A7 | CYP3A4 | 0.957 |
CRABP1 | CYP26B1 | 0.956 |
AOX1 | CYP2A6 | 0.954 |
CYP1A2 | CYP3A4 | 0.952 |
AOX1 | CYP2B6 | 0.95 |
CYP1A1 | CYP3A4 | 0.95 |
CYP3A4 | CYP2A6 | 0.949 |
AOX1 | CYP3A4 | 0.948 |
CYP3A4 | CYP2B6 | 0.948 |
CYP1A1 | CYP3A5 | 0.946 |
CYP3A7 | CYP1A1 | 0.945 |
CYP1A2 | CYP3A5 | 0.945 |
CYP2B6 | CYP3A5 | 0.944 |
CYP4A11 | CYP2A6 | 0.944 |
CYP2B6 | CYP4A11 | 0.943 |
CYP2A6 | CYP3A5 | 0.942 |
CYP1A1 | CYP4A11 | 0.942 |
CYP3A7 | CYP2A6 | 0.941 |
CYP3A7 | CYP2B6 | 0.94 |
CYP3A7 | CYP1A2 | 0.939 |
CYP1A2 | CYP4A11 | 0.939 |
CYP3A4 | CYP4A11 | 0.939 |
CYP4A11 | CYP3A5 | 0.933 |
CYP3A7 | CYP4A11 | 0.933 |
CYP1A2 | CYP2A6 | 0.932 |
CYP1A2 | CYP2B6 | 0.93 |
CYP2S1 | CYP26B1 | 0.93 |
CYP1A1 | ALDH1A1 | 0.929 |
CYP1A1 | CYP26B1 | 0.929 |
CYP3A4 | CYP2S1 | 0.929 |
CYP2B6 | CYP26B1 | 0.929 |
AOX1 | CYP1A2 | 0.929 |
CYP1A1 | CYP2B6 | 0.928 |
CYP2B6 | ALDH1A2 | 0.928 |
CYP2B6 | ALDH1A1 | 0.928 |
CYP3A4 | ALDH1A1 | 0.926 |
CYP2S1 | CYP3A5 | 0.925 |
CYP3A4 | CYP26B1 | 0.925 |
CYP4A11 | CYP26B1 | 0.925 |
CYP4A11 | CYP2S1 | 0.924 |
CYP1A1 | CYP2A6 | 0.924 |
CYP2A6 | CYP26B1 | 0.922 |
CYP3A7 | CYP26B1 | 0.922 |
CYP3A7 | CYP2S1 | 0.922 |
CYP1A2 | CYP26B1 | 0.921 |
CYP1A1 | AOX1 | 0.921 |
ALDH1A1 | CYP3A5 | 0.921 |
CYP3A5 | CYP26B1 | 0.92 |
CYP1A1 | CYP2S1 | 0.92 |
CYP1A2 | CYP2S1 | 0.919 |
CYP2A6 | ALDH1A1 | 0.916 |
CYP3A4 | CYP3A5 | 0.916 |
CYP1A2 | ALDH1A1 | 0.916 |
CYP3A7 | ALDH1A2 | 0.913 |
CYP2S1 | ALDH1A2 | 0.912 |
AOX1 | CYP3A5 | 0.912 |
CYP2B6 | CYP2A6 | 0.911 |
CYP3A7 | ALDH1A1 | 0.909 |
CYP1A1 | ALDH1A2 | 0.909 |
AOX1 | CYP26B1 | 0.908 |
CYP3A4 | ALDH1A2 | 0.908 |
AOX1 | CYP4A11 | 0.907 |
CYP3A7 | AOX1 | 0.906 |
AOX1 | CYP2S1 | 0.906 |
ALDH1A2 | CYP3A5 | 0.905 |
NANOS2 | CYP26B1 | 0.905 |
CYP2A6 | ALDH1A2 | 0.905 |
CYP2S1 | ALDH1A1 | 0.904 |
CYP3A7 | CYP3A5 | 0.903 |
CYP4A11 | ALDH1A1 | 0.903 |
CYP4A11 | ALDH1A2 | 0.903 |
CYP1A2 | ALDH1A2 | 0.902 |
# | 8854 (ALDH1A2) | 216 (ALDH1A1) | 1551 (CYP3A7) | 1381 (CRABP1) | 316 (AOX1) | 1544 (CYP1A2) | 1543 (CYP1A1) | 1576 (CYP3A4) | 1555 (CYP2B6) | 1579 (CYP4A11) | 1548 (CYP2A6) | 29785 (CYP2S1) | 1577 (CYP3A5) | 339345 (NANOS2) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8854 (ALDH1A2) | 1.00 | 0.66 | 0.37 | 0.37 | 0.32 | 0.40 | 0.43 | 0.40 | 0.38 | 0.37 | 0.33 | 0.34 | 0.44 | 0.31 |
216 (ALDH1A1) | 0.66 | 1.00 | 0.34 | 0.25 | 0.42 | 0.41 | 0.40 | 0.43 | 0.38 | 0.32 | 0.35 | 0.35 | 0.39 | 0.35 |
1551 (CYP3A7) | 0.37 | 0.34 | 1.00 | 0.33 | 0.37 | 0.59 | 0.89 | 0.79 | 0.68 | 0.63 | 0.63 | 0.66 | 0.96 | 0.59 |
1381 (CRABP1) | 0.37 | 0.25 | 0.33 | 1.00 | 0.42 | 0.37 | 0.46 | 0.35 | 0.24 | 0.17 | 0.37 | 0.43 | 0.34 | 1.00 |
316 (AOX1) | 0.32 | 0.42 | 0.37 | 0.42 | 1.00 | 0.48 | 0.48 | 0.51 | 0.38 | 0.26 | 0.43 | 0.47 | 0.41 | 0.82 |
1544 (CYP1A2) | 0.40 | 0.41 | 0.59 | 0.37 | 0.48 | 1.00 | 0.68 | 0.72 | 0.76 | 0.59 | 0.78 | 0.76 | 0.63 | 0.82 |
1543 (CYP1A1) | 0.43 | 0.40 | 0.89 | 0.46 | 0.48 | 0.68 | 1.00 | 0.85 | 0.62 | 0.59 | 0.63 | 0.67 | 0.94 | 1.00 |
1576 (CYP3A4) | 0.40 | 0.43 | 0.79 | 0.35 | 0.51 | 0.72 | 0.85 | 1.00 | 0.62 | 0.55 | 0.65 | 0.63 | 0.81 | 0.82 |
1555 (CYP2B6) | 0.38 | 0.38 | 0.68 | 0.24 | 0.38 | 0.76 | 0.62 | 0.62 | 1.00 | 0.79 | 0.90 | 0.91 | 0.65 | 0.37 |
1579 (CYP4A11) | 0.37 | 0.32 | 0.63 | 0.17 | 0.26 | 0.59 | 0.59 | 0.55 | 0.79 | 1.00 | 0.68 | 0.69 | 0.63 | 0.21 |
1548 (CYP2A6) | 0.33 | 0.35 | 0.63 | 0.37 | 0.43 | 0.78 | 0.63 | 0.65 | 0.90 | 0.68 | 1.00 | 0.93 | 0.59 | 0.82 |
29785 (CYP2S1) | 0.34 | 0.35 | 0.66 | 0.43 | 0.47 | 0.76 | 0.67 | 0.63 | 0.91 | 0.69 | 0.93 | 1.00 | 0.61 | 1.00 |
1577 (CYP3A5) | 0.44 | 0.39 | 0.96 | 0.34 | 0.41 | 0.63 | 0.94 | 0.81 | 0.65 | 0.63 | 0.59 | 0.61 | 1.00 | 0.59 |
339345 (NANOS2) | 0.31 | 0.35 | 0.59 | 1.00 | 0.82 | 0.82 | 1.00 | 0.82 | 0.37 | 0.21 | 0.82 | 1.00 | 0.59 | 1.00 |
Protein Official symbol | Source Organism | Tissue of Expression | Level of hypoxia | Altitude | Duration of experiment | Level of expression | Fold change | Experiment details | geographical location | ethnicity of the patients | Control group | Control (Fold change) | Reference (PMID) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CYP26B1 | Toad | Brain | - | 3464 m | 33 day | upregulated | 2.250185492 | RNA-seq | Tibetan Plateau | Asiatic toad | 1 | Zoige (High altitute Toad) Vs Chengdu (Low altitude toad) - | 28673260 |
CYP26B1 | Toad | Heart | - | 3464 m | 33 day | upregulated | 3.446391022 | RNA-seq | Tibetan Plateau | Asiatic toad | 1 | Zoige (High altitute Toad) Vs Chengdu (Low altitude toad) - | 28673260 |
TF | TF Entrez | Gene | Gene Entrez | Type | PMID | Database |
---|
miRTarBase ID | miRNA | Species (miRNA) | Protein Official Symbol | Human Entrez ID | Species (Target Gene) | Experiments | Support Type | References (PMID) |
---|---|---|---|---|---|---|---|---|
MIRT027171 | hsa-miR-103a-3p | Homo sapiens | CYP26B1 | 56603 | Homo sapiens | Sequencing | Functional MTI (Weak) | 20371350 |
MIRT031931 | hsa-miR-16-5p | Homo sapiens | CYP26B1 | 56603 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 21572407 |
MIRT031931 | hsa-miR-16-5p | Homo sapiens | CYP26B1 | 56603 | Homo sapiens | Sequencing//PAR-CLIP | Functional MTI (Weak) | 20371350 |
MIRT558511 | hsa-miR-15a-5p | Homo sapiens | CYP26B1 | 56603 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 21572407 |
MIRT558495 | hsa-miR-3912-5p | Homo sapiens | CYP26B1 | 56603 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 21572407 |
MIRT558496 | hsa-miR-3671 | Homo sapiens | CYP26B1 | 56603 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 21572407 |
MIRT558501 | hsa-miR-5697 | Homo sapiens | CYP26B1 | 56603 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 21572407 |
MIRT558503 | hsa-miR-4703-5p | Homo sapiens | CYP26B1 | 56603 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 20371350 |
MIRT558494 | hsa-miR-607 | Homo sapiens | CYP26B1 | 56603 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 20371350 |
MIRT558497 | hsa-miR-4524b-5p | Homo sapiens | CYP26B1 | 56603 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 20371350 |
MIRT558498 | hsa-miR-4524a-5p | Homo sapiens | CYP26B1 | 56603 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 20371350 |
MIRT558507 | hsa-miR-424-5p | Homo sapiens | CYP26B1 | 56603 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 20371350 |
MIRT558508 | hsa-miR-195-5p | Homo sapiens | CYP26B1 | 56603 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 20371350 |
MIRT558505 | hsa-miR-562 | Homo sapiens | CYP26B1 | 56603 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 20371350 |
MIRT558512 | hsa-miR-497-5p | Homo sapiens | CYP26B1 | 56603 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 21572407 |
MIRT558500 | hsa-miR-6826-5p | Homo sapiens | CYP26B1 | 56603 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 20371350 |
MIRT558506 | hsa-miR-503-5p | Homo sapiens | CYP26B1 | 56603 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 20371350 |
MIRT558507 | hsa-miR-424-5p | Homo sapiens | CYP26B1 | 56603 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 21572407 |
MIRT558512 | hsa-miR-497-5p | Homo sapiens | CYP26B1 | 56603 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 20371350 |
MIRT558496 | hsa-miR-3671 | Homo sapiens | CYP26B1 | 56603 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 20371350 |
MIRT558510 | hsa-miR-15b-5p | Homo sapiens | CYP26B1 | 56603 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 21572407 |
MIRT558502 | hsa-miR-646 | Homo sapiens | CYP26B1 | 56603 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 21572407 |
MIRT558504 | hsa-miR-3942-5p | Homo sapiens | CYP26B1 | 56603 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 21572407 |
MIRT558508 | hsa-miR-195-5p | Homo sapiens | CYP26B1 | 56603 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 21572407 |
MIRT558510 | hsa-miR-15b-5p | Homo sapiens | CYP26B1 | 56603 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 20371350 |
MIRT558501 | hsa-miR-5697 | Homo sapiens | CYP26B1 | 56603 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 20371350 |
MIRT558505 | hsa-miR-562 | Homo sapiens | CYP26B1 | 56603 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 21572407 |
MIRT558494 | hsa-miR-607 | Homo sapiens | CYP26B1 | 56603 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 21572407 |
MIRT558497 | hsa-miR-4524b-5p | Homo sapiens | CYP26B1 | 56603 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 21572407 |
MIRT558504 | hsa-miR-3942-5p | Homo sapiens | CYP26B1 | 56603 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 20371350 |
MIRT558509 | hsa-miR-6838-5p | Homo sapiens | CYP26B1 | 56603 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 21572407 |
MIRT558502 | hsa-miR-646 | Homo sapiens | CYP26B1 | 56603 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 20371350 |
MIRT558503 | hsa-miR-4703-5p | Homo sapiens | CYP26B1 | 56603 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 21572407 |
MIRT558498 | hsa-miR-4524a-5p | Homo sapiens | CYP26B1 | 56603 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 21572407 |
MIRT558499 | hsa-miR-589-3p | Homo sapiens | CYP26B1 | 56603 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 21572407 |
MIRT558500 | hsa-miR-6826-5p | Homo sapiens | CYP26B1 | 56603 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 21572407 |
MIRT558506 | hsa-miR-503-5p | Homo sapiens | CYP26B1 | 56603 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 21572407 |
MIRT558509 | hsa-miR-6838-5p | Homo sapiens | CYP26B1 | 56603 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 20371350 |
MIRT558511 | hsa-miR-15a-5p | Homo sapiens | CYP26B1 | 56603 | Homo sapiens | PAR-CLIP | Functional MTI (Weak) | 20371350 |
ID | GO ID | GO Term | GO Type |
---|---|---|---|
56603 | GO:0016709 | oxidoreductase activity | GOTERM_MF_DIRECT |
56603 | GO:0009954 | proximal/distal pattern formation | GOTERM_BP_DIRECT |
56603 | GO:0005506 | iron ion binding | GOTERM_MF_DIRECT |
56603 | GO:0001768 | establishment of T cell polarity | GOTERM_BP_DIRECT |
56603 | GO:0006766 | vitamin metabolic process | GOTERM_BP_DIRECT |
56603 | GO:0006954 | inflammatory response | GOTERM_BP_DIRECT |
56603 | GO:0001972 | fibronectin binding | GOTERM_MF_DIRECT |
56603 | GO:0031090 | organelle membrane | GOTERM_CC_DIRECT |
56603 | GO:0045580 | regulation of T cell differentiation | GOTERM_BP_DIRECT |
56603 | GO:0055114 | oxidation-reduction process | GOTERM_BP_DIRECT |
56603 | GO:0061436 | establishment of skin barrier | GOTERM_BP_DIRECT |
56603 | GO:0070268 | cornification | GOTERM_BP_DIRECT |
56603 | GO:0007283 | spermatogenesis | GOTERM_BP_DIRECT |
56603 | GO:0004497 | malate synthase activity | GOTERM_MF_DIRECT |
56603 | GO:0005789 | endoplasmic reticulum membrane | GOTERM_CC_DIRECT |
56603 | GO:0006805 | xenobiotic metabolic process | GOTERM_BP_DIRECT |
56603 | GO:0010628 | positive regulation of gene expression | GOTERM_BP_DIRECT |
56603 | GO:0030326 | embryonic limb morphogenesis | GOTERM_BP_DIRECT |
56603 | GO:0034653 | retinoic acid catabolic process | GOTERM_BP_DIRECT |
56603 | GO:0005737 | cytoplasm | GOTERM_CC_DIRECT |
56603 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway | GOTERM_BP_DIRECT |
56603 | GO:0060349 | bone morphogenesis | GOTERM_BP_DIRECT |
56603 | GO:0008401 | arachidonic acid epoxygenase activity | GOTERM_MF_DIRECT |
56603 | GO:0016705 | oxidoreductase activity | GOTERM_MF_DIRECT |
56603 | GO:0001709 | cell fate determination | GOTERM_BP_DIRECT |
56603 | GO:0007140 | male meiosis | GOTERM_BP_DIRECT |
56603 | GO:0048384 | retinoic acid receptor signaling pathway | GOTERM_BP_DIRECT |
56603 | GO:0071300 | cellular response to retinoic acid | GOTERM_BP_DIRECT |
56603 | GO:2001037 | positive regulation of tongue muscle cell differentiation | GOTERM_BP_DIRECT |
56603 | GO:0043587 | tongue morphogenesis | GOTERM_BP_DIRECT |
56603 | GO:0020037 | heme binding | GOTERM_MF_DIRECT |
Protein Official Symbol | Human Entrez ID | Disease Name | Disease Id | Disease Semantic Type | Semantic score | DSI | DPI | Disease Type |
---|---|---|---|---|---|---|---|---|
CYP26B1 | 56603 | Obesity | C0028754 | Disease or Syndrome | 0.3 | 0.701 | 0.379 | disease |
CYP26B1 | 56603 | Mouth Diseases | C0026636 | Disease or Syndrome | 0.3 | 0.701 | 0.379 | group |
CYP26B1 | 56603 | Squamous cell carcinoma of esophagus | C0279626 | Neoplastic Process | 0.3 | 0.701 | 0.379 | disease |
CYP26B1 | 56603 | Craniosynostosis | C0010278 | Disease or Syndrome | 0.41 | 0.701 | 0.379 | disease |
CYP26B1 | 56603 | Osteogenesis Imperfecta | C0029434 | Congenital Abnormality; Disease or Syndrome | 0.3 | 0.701 | 0.379 | disease |
CYP26B1 | 56603 | RADIOHUMERAL FUSIONS WITH OTHER SKELETAL AND CRANIOFACIAL ANOMALIES | C3280729 | Disease or Syndrome | 0.6 | 0.701 | 0.379 | disease |
CYP26B1 | 56603 | Schizophrenia | C0036341 | Mental or Behavioral Dysfunction | 0.11 | 0.701 | 0.379 | disease |
Protein Official Symbol | Human Entrez ID | drug_claim_primary_name | drug_name | drug_chembl_id | interaction_types |
---|---|---|---|---|---|
CYP26B1 | 56603 | TALAROZOLE | TALAROZOLE | CHEMBL459505 | None |